Esperion Therapeutics ESPR Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Esperion Therapeutics’s reported figures.
Plus components not separately reported this period.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's total debt?
- Esperion Therapeutics (ESPR) reported total debt of $155.23M in Q1 2026.
- How has Esperion Therapeutics's total debt changed year-over-year?
- Esperion Therapeutics's total debt increased by 6.1% year-over-year, from $146.24M to $155.23M.
- What is the long-term trend for Esperion Therapeutics's total debt?
- Over 5 years (2020 to 2025), Esperion Therapeutics's total debt has grown at a 91.4% compound annual growth rate (CAGR), from $6.04M to $154.97M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.